Melatonin Inhibits OGD/R-Induced H9c2 Cardiomyocyte Pyroptosis via Regulation of MT2/miR-155/FOXO3a/ARC Axis.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Melatonin | decrease | OGD/R-induced pyroptosis of H9c2 cells | H9c2 cardiomyocytes | - | could inhibit | #1 |
upregulation of FOXO3a | decrease | OGD/R-induced pyroptosis | H9c2 cardiomyocytes | - | contributed to the antipyroptotic effect | #2 |
Melatonin | decrease | miR-155 expression | OGD/R-exposed H9c2 cells | - | reduced | #3 |
reduced miR-155 expression | increase | FOXO3a upregulation | OGD/R-exposed H9c2 cells | - | led to | #4 |
reduced miR-155 expression | decrease | inhibition of pyroptosis | OGD/R-exposed H9c2 cells | - | led to | #5 |
miR-155 inhibitor | increase | the antipyroptotic effect of melatonin | OGD/R-exposed H9c2 cells | - | enhanced | #6 |
melatonin receptor 2 (MT2) siRNA | increase | Melatonin-induced downregulation of miR-155 | - | - | reversed | #7 |
melatonin receptor 2 (MT2) siRNA | decrease | Melatonin-induced upregulation of FOXO3a | - | - | reversed | #8 |
Melatonin treatment | increase | apoptosis repressor with caspase recruitment domain (ARC) | - | - | led to an increased level of | #9 |
FOXO3a siRNA | decrease | Melatonin-induced increased level of ARC | - | - | inhibited | #10 |
silencing ARC by siRNA | decrease | the antipyroptotic actions of melatonin | OGD/R-exposed H9c2 cells | - | significantly blocked | #11 |
ARC overexpression | increase | the antipyroptotic actions of melatonin | OGD/R-exposed H9c2 cells | - | enhanced | #12 |
Melatonin | decrease | OGD/R-induced pyroptosis | cardiomyocytes | - | prevented | #13 |
Emerging literature suggests that pyroptosis plays a critical role in ischemia/hypoxia (I/R) -induced myocardial injury. Melatonin has been implicated in attenuating I/R-induced injury of cardiomyocytes. Nevertheless, whether melatonin inhibits I/R-induced pyroptosis of cardiomyocytes and the underlying molecular mechanisms remain unexploited.H9c2 cardiomyocytes were cultured under oxygen-glucose deprivation/reperfusion (OGD/R) condition to establish a myocardial pyroptosis model in vitro. OGD/R-induced pyroptosis was evaluated by CCK-8 assay, IL-1β and IL-18 release, and western blotting. Luciferase reporter assay was utilized to validate the association between miR-155 and Forkhead box O3a (FOXO3a).Melatonin could inhibit OGD/R-induced pyroptosis of H9c2 cells and upregulation of FOXO3a contributed to the antipyroptotic effect of melatonin. Melatonin reduced miR-155 expression, which led to FOXO3a upregulation and inhibition of pyroptosis in OGD/R-exposed H9c2 cells. miR-155 inhibitor enhanced the antipyroptotic effect of melatonin in OGD/R-exposed H9c2 cells. Melatonin-induced downregulation of miR-155 and upregulation of FOXO3a were reversed by melatonin receptor 2 (MT2) siRNA. Melatonin treatment also led to an increased level of apoptosis repressor with caspase recruitment domain (ARC), which was inhibited by FOXO3a siRNA. Moreover, silencing ARC by siRNA significantly blocked the antipyroptotic actions of melatonin, whereas ARC overexpression enhanced the antipyroptotic actions of melatonin in OGD/R-exposed H9c2 cells.Our findings demonstrated that melatonin prevented OGD/R-induced pyroptosis via regulating the MT2/miR-155/FOXO3a/ARC axis in cardiomyocytes.